Stockreport

Why Analysts See Mersana's Story Shifting To Deal And CVR Outcomes After $1B Buyout [Yahoo! Finance]

Mersana Therapeutics, Inc.  (MRSN) 
Last mersana therapeutics, inc. earnings: 2/28 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana
PDF up to roughly 7.06 %, underscoring how closely the stock is now tethered to the pending acquisition terms and CVR dynamics. With revenue growth assumptions holding near [Read more]